Alveolus, Tb-Sts Tracheobronchial Stent System
Prosthesis, Tracheal, Expandable. 510(k) K033053, from Alveolus, Inc. (Charlotte, NC). Product code JCT, class 2.
As of Nov 21, 2026, K033053 is an FDA 510(k) held by Alveolus, Inc., substantially equivalent on Feb 25, 2004 after 149 days, with no recalls tied to it in FDA's recall database.
- Review time: 149 days
- Recalls: 0
- Cited as a predicate by: 1 device
The Alveolus TB-STS TM Tracheobronchial Stent System is indicated for use in the treatment of tracheobronchial strictures and airway compression (stenosis) produced by malignant neoplasms. Because the device is removable it may also be used to treat conditions such as tracheo-esophageal fistula resulting from malignancies and strictures resulting from surgical anastomosis of the airway in…
- Alveolus Inc., Tb-Sts Tracheobronchial Stent SystemK030947 · Alveolus, Inc. · May 15, 2003
- Rusch Polyflex Stent KitK013266 · Rusch Intl. · Nov 27, 2001
- EndoxaneK971509 · Novatech SA · Aug 21, 1997
- UltraflexK963241 · Boston Scientific Corp · Nov 14, 1996
- Aero Tracheobronchial Stent System, Model 90129-2XXK062511 · Alveolus, Inc. · Jan 31, 2007
- Ultraflex™ Tracheobronchial Stent SystemK230269 · Boston Scientific Corporation · Jul 14, 2023
- Through the Scope Tracheal Stent SystemK220424 · Micro-Tech (Nanjing) Co., Ltd. · Jul 8, 2022
- Tracheal Stent System (Y-Shaped)K212403 · Micro-Tech (Nanjing) Co., Ltd. · Oct 30, 2021
- Tracheal Stent SystemK202204 · Micro-Tech (Nanjing) Co., Ltd. · Sep 1, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 29, 2003
- Review panel
- General, Plastic Surgery
- Regulation
- 21 CFR 878.3720
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files